Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Adesuwa S. Ogbomo"'
Autor:
Ran Jin, Adesuwa S. Ogbomo, Neil A. Accortt, Lincy S. Lal, Geetanjali Bishi, Darcie Sandschafer, Jerome H. Goldschmidt
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: Bevacizumab-awwb (MVASI ® ) was the first U.S. Food and Drug Administration-approved biosimilar to Avastin ® (reference product [RP]) for the treatment of several different types of cancers, including metastatic colorectal cancer (mCRC)
Externí odkaz:
https://doaj.org/article/1e3bd947becc4f728269150e570d3bc4
Autor:
Ran Jin, Adesuwa S. Ogbomo, Neil A. Accortt, Lincy S. Lal, Geetanjali Bishi, Darcie Sandschafer, Jerome H. Goldschmidt
Publikováno v:
Journal of Clinical Oncology. 40:e15581-e15581
e15581 Background: Bevacizumab-awwb (MVASI) was the first FDA-approved biosimilar to Avastin (reference product, RP). Real-world data on effectiveness and safety remain limited and may help address barriers to utilization. Methods: Adult patients who
Autor:
Naomi B. Haas, Rituparna Bhattacharya, Adesuwa S. Ogbomo, Kentaro Imai, Santosh Gautam, Jackie Rogerio, Rebekah Yu, Jatin Chhabra, Murali Sundaram
Publikováno v:
Journal of Clinical Oncology. 40:e16526-e16526
e16526 Background: Real world evidence (RWE) on patient outcomes among early-stage non-metastatic renal cell carcinoma (RCC) patients (pts) of different risk groups are limited. This RWE study evaluated disease free survival (DFS) and overall surviva
Autor:
Robert L. Wahl, Tess Konen, Adesuwa S. Ogbomo, Lorraine L. Cameron, Marie S. O’Neill, Carina J. Gronlund
Publikováno v:
International Journal of Biometeorology. 61:833-843
With climate change, extreme heat (EH) events are increasing, so it is important to understand who is vulnerable to heat-associated morbidity. We determined the association between EH and hospitalizations for all natural causes; cardiovascular, respi